Kidney et al., 2016 - Google Patents
Calciotropic HormonesKidney et al., 2016
- Document ID
- 1517070931541876816
- Author
- Kidney I
- Cherniack E
- Troen B
- Publication year
- Publication venue
- Osteoporosis in Older Persons: Advances in Pathophysiology and Therapeutic Approaches
External Links
Snippet
The calcium–vitamin D–parathyroid hormone system plays a critical role in both health and disease. Despite longstanding acceptance of its importance in maintaining the skeleton, recent and accumulating data have significantly enhanced our understanding of the …
- 229940088597 hormone 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Khazai et al. | Calcium and vitamin D: skeletal and extraskeletal health | |
Pérez-López | Vitamin D and its implications for musculoskeletal health in women: an update | |
Shinchuk et al. | Vitamin D and rehabilitation: improving functional outcomes | |
Nair et al. | Vitamin D: The “sunshine” vitamin | |
ES2689700T3 (en) | Nutritional intervention to improve muscle function and endurance | |
Holick | Vitamin D in health and disease: Vitamin D for health and in chronic kidney disease | |
Cavalier et al. | Vitamin D: current status and perspectives | |
Muscogiuri et al. | Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives | |
Kennel et al. | Vitamin D deficiency in adults: when to test and how to treat | |
US11547713B2 (en) | Nutritional intervention for improving muscular function and strength | |
Demontiero et al. | Supplementation with vitamin D and calcium in long-term care residents | |
US9259430B2 (en) | Nutritional intervention for improving muscular function and strength | |
Cherniack et al. | Calciotropic hormones | |
Meunier | Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis | |
US20170106004A1 (en) | Nutritional Intervention for Improving Muscular Function and Strength | |
Bischoff-Ferrari | Validated treatments and therapeutic perspectives regarding nutritherapy | |
Barnes et al. | Vitamin D: Status, supplementation and immunomodulation | |
Agarwal et al. | Hyperparathyroidism and malnutrition with severe vitamin D deficiency | |
Vondracek | Managing osteoporosis in postmenopausal women | |
Holick | Vitamin D deficiency in obesity and health consequences | |
Geller et al. | Vitamin D therapy | |
Kidney et al. | Calciotropic Hormones | |
Drezner et al. | Newer knowledge of vitamin D and its metabolites in health and disease. | |
Domingues-Faria et al. | Vitamin D Signaling and Skeletal Muscle Cells | |
Dawson-Hughes | The role of vitamin D in fracture prevention |